Trial reportClinical ophthalmology (Auckland, N.Z.)2023
Comparing Visual Performance and Subjective Outcomes with an Enhanced Monofocal Intraocular Lens When Targeted for Emmetropia or Monovision.
Trial report in Clinical ophthalmology (Auckland, N.Z.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 8 citations in OpenAlex.
- Realistic Visual Acuity and Patient Satisfaction After Simultaneous Bilateral Tecnis Eyhance DIB00 Monofocal Plus Lens Implantation During a 12-Month Follow-Up Period in a Single-Center Study.Medicina (Kaunas, Lithuania) · 2026Article
- Evaluation of spectacle independence with the Dutch Patient-Reported Spectacle Independence Questionnaire.Journal of cataract and refractive surgery · 2026Observational
- Clinical Performance of an Enhanced Monofocal IOL Bilaterally Implanted in Patients Targeted for Monovision: A Prospective Study.Journal of clinical medicine · 2026Article
- Refractive Surprises After Cataract Surgery: Identification and Management in Optometric Practice- A Comprehensive Review.Clinical optometry · 2026Review
- Enhanced Monovision Intraocular Lenses: Current Status and Future Perspectives-Systematic Review.Biomedicines · 2025Review
- A comparative study of mini-monovision, crossed mini-monovision, and emmetropia with enhanced monofocal intraocular lenses.Scientific reports · 2025Article
- Outcomes of mini-monovision with monofocal, enhanced monofocal and extended depth-of-focus intraocular lenses.Frontiers in medicine · 2025Review
- Visual Performance and Subjective Outcomes with Enhanced Monofocal Intraocular Lens Implantation Targeted for Emmetropia or Modest Monovision.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- Surgical considerations in hyperopic cataract patients: optimizing outcomes and reducing complications.Frontiers in medicine · 2025Review
- Comparison of bilateral implantation of monofocal intraocular lenses with enhanced intermediate function targeting with - 2.00 D and emmetropia in moderate to high myopic Asian patients.Eye and vision (London, England) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate relative visual performance and subjective outcomes after implantation of the TECNIS Eyhance™ intraocular lens (IOL) targeted for bilateral emmetropia or monovision. Methods: This was a prospective, single-center randomized, patient-masked trial. Patients were implanted with the enhanced IOL targeted for bilateral emmetropia or slight monovision (-0.75 D in the non-dominant eye). At 3 months the binocular visual acuity (VA) was measured at distance, intermediate and near, along with low contrast VA in photopic and mesopic conditions, and the distance corrected defocus curve. Questionnaires related to spectacle independence, satisfaction, visual symptoms, and functional vision were administered. Results: Data from 71 subjects (34 Emmetropia, 37 Monovision) were analyzed. There was no difference in the mean uncorrected distance VA (p = 0.11), but uncorrected intermediate and near VAs were one line better in the Monovision group (p = 0.02 and 0.01, respectively). Mesopic and photopic low contrast VA were similar between groups. There was a trend for less difficulty and higher satisfaction with near and intermediate vision in the Monovision group, but no significant differences in any of the subjective questionnaires. Difficulty reading was the most reported concern in both groups, though 93% of all subjects reported "little" or "no" difficulty with daily activities. Overall, 82% of subjects were "completely" or "very" happy with their lens choice. Conclusion: Using this enhanced IOL with slight monovision in the non-dominant eye increased intermediate and near VA with no apparent effect on low contrast distance VA, subjective visual quality, or satisfaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.